TherapeuticsMD, Inc.

NasdaqGS TXMD

TherapeuticsMD, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -180.26%

TherapeuticsMD, Inc. EBITDA Margin is -180.26% for the Trailing 12 Months (TTM) ending September 30, 2024. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • TherapeuticsMD, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was -99.73%, a 34.09% change year over year.
  • TherapeuticsMD, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was -151.32%, a 45.41% change year over year.
  • TherapeuticsMD, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was -277.17%, a 29.11% change year over year.
Key data
Date EBITDA Margin EBIT Margin Depreciation and Amortization EBIT
Market news
Loading...
NasdaqGS: TXMD

TherapeuticsMD, Inc.

CEO Mr. Marlan D. Walker J.D.
IPO Date May 9, 2007
Location United States
Headquarters 951 Yamato Road
Employees 1
Sector Health Care
Industries
Description

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Similar companies

PRFX

PainReform Ltd.

USD 2.74

-3.52%

IRWD

Ironwood Pharmaceuticals, Inc.

USD 3.65

-3.18%

LFCR

Lifecore Biomedical, Inc.

USD 6.43

1.10%

ALKS

Alkermes plc

USD 28.50

0.53%

CPIX

Cumberland Pharmaceuticals Inc.

USD 2.67

14.59%

ANIP

ANI Pharmaceuticals, Inc.

USD 54.16

0.43%

TKNO

Alpha Teknova, Inc.

USD 7.91

-2.10%

ORGO

Organogenesis Holdings Inc.

USD 2.89

-3.67%

EVOK

Evoke Pharma, Inc.

USD 4.31

3.36%

AQST

Aquestive Therapeutics, Inc.

USD 3.05

-1.93%

StockViz Staff

January 15, 2025

Any question? Send us an email